Luo Wenjie, Huang Hao, Zhou Yuan, Min Jieshu, Wang Changxu
School of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, China.
Department of General Surgery, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, China.
Support Care Cancer. 2025 Feb 7;33(3):163. doi: 10.1007/s00520-025-09228-9.
The three-step analgesic ladder, recommended by the World Health Organization (WHO), serves as a guideline for managing cancer pain, progressing from non-opioids to weak opioids and strong opioids based on pain intensity. Despite its widespread use, challenges in standardizing its application persist, impacting medication safety and efficacy. This study aimed to implement the PDCA (Plan-Do-Check-Act) cycle in hospital inpatient pharmacies to improve the management and compliance of the three-step analgesic ladder for cancer pain patients.
A mixed-methods study design combining retrospective and prospective components was employed. Retrospective data on prescription compliance for three-step analgesics were collected from June 2021 to March 2022 (pre-implementation). The prospective randomized cohort study enrolled 160 advanced cancer patients from June 2022 to March 2023 (intervention and control groups). Interventions included paperless prescription management, enhanced patient education, and structured follow-ups.
The prescription compliance rate improved significantly from 72.32% before implementation to 92.92% after implementation (P < 0.05). Satisfaction rates among medical staff with the management process increased from 81.09 to 94.22%, indicating enhanced efficiency and accuracy. Satisfaction rates reflected healthcare professionals' evaluation of improved prescription practices and reduced workload. Pain intensity, measured by the visual analog scale (VAS), decreased significantly in the intervention group compared to the control group (2.26 ± 0.78 vs. 3.07 ± 0.15; P < 0.01).
The implementation of the PDCA cycle significantly improved compliance with the WHO three-step analgesic ladder, enhanced pain management outcomes, and increased satisfaction among healthcare professionals. Future studies should explore integrating patient-specific assessments to optimize individualized pain management strategies.
世界卫生组织(WHO)推荐的三阶梯镇痛法是管理癌痛的指南,根据疼痛强度从非阿片类药物逐步过渡到弱阿片类药物和强阿片类药物。尽管其应用广泛,但在标准化应用方面仍存在挑战,影响药物安全性和疗效。本研究旨在将PDCA(计划-执行-检查-行动)循环应用于医院住院药房,以改善癌症疼痛患者三阶梯镇痛法的管理和依从性。
采用回顾性和前瞻性相结合的混合方法研究设计。收集2021年6月至2022年3月(实施前)三阶梯镇痛药处方依从性的回顾性数据。前瞻性随机队列研究纳入了2022年6月至2023年3月的160例晚期癌症患者(干预组和对照组)。干预措施包括无纸化处方管理、加强患者教育和结构化随访。
处方依从率从实施前的72.32%显著提高到实施后的92.92%(P<0.05)。医务人员对管理过程的满意度从81.09%提高到94.22%,表明效率和准确性得到提高。满意度反映了医疗保健专业人员对改进处方实践和减轻工作量的评价。与对照组相比,干预组采用视觉模拟量表(VAS)测量的疼痛强度显著降低(2.26±0.78 vs. 3.07±0.15;P<0.01)。
PDCA循环的实施显著提高了对WHO三阶梯镇痛法的依从性,改善了疼痛管理效果,并提高了医疗保健专业人员的满意度。未来的研究应探索整合患者特异性评估,以优化个体化疼痛管理策略。